Surgery Partners, Inc. Common Stock(SGRY)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Snapshot
$15.30
- 52-Week Range
- $11.41 – $24.10
- YTD
- +0.28%
- IV Rank (30D)
- 18.57
- Straddle Price
- $1.88
- P/C Vol Ratio
- 0.17
- Market Cap
- $2.0B
Fair Value
+50.0% vs price
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.53% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 10.03% (VRP-adj) |
| WACC | 6.74% |
| Volatility Risk Premium | +69.9pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 14.7% |
| Rev. Growth (YoY, DCF input) | -1.9% |
| DCF Horizon | 10 years explicit + fade |
| Free Cash Flow (TTM) | $0.2B |
| Return on Equity (TTM) | -4.5% |
| Book / Price | 162.7% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 100.0% |
| FCF Margin (TTM) | 6.2% |
| Debt / Equity | 1.17 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | +3.4% (reverse-DCF on current price) |
| SMA 50 | $13.74 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $13.75 |
| Bollinger Width / SMA20 | 86.7% (drives anchor stability) |
| Net Debt | $3.4B |
| Market Cap | $2B |
Peers used for multiples: CNC, ELV, HUM, PGNY, UNH
(filtered from 8 ETF-co-members; sector bias active)
Blended Fair Value
$24.53
Current Price
$15.31
Deviation
+50.0%
Forward-Return Rank
LONG
gates ✓
?
| Horizon | Expected α | z Pred | Blended z | Rank % | Active? |
|---|---|---|---|---|---|
| 21d | -5.4% ⚠ | -0.78 | +0.54 | 59.0% | — |
| 42d | -8.4% ⚠ | -0.92 | +0.47 | 53.1% | — |
| 63d | -6.9% ⚠ | -0.39 | +0.74 | 65.5% | — |
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon).
For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference.
⚠ flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $2.96 | 48% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 30.3× · 4 peers |
| Peer EV/EBITDA | $70.62 | 14% | median 19.1× · 5 peers |
| Peer P/B | $57.37 | 19% | median 2.4× · 5 peers |
| Peer P/S | $11.54 | 19% | median 0.4× · 5 peers |
| Market Anchor (SMA50) | $13.74 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
As of 2026-06-12 · updated 2026-06-12 20:59:55.687000
Info
- Industry (SIC)
- SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC (8062)
- Exchange
- XNAS
- Market Cap
- $2.0B
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
Price History
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +4.14% | 6 |
| Feb | +1.14% | 6 |
| Mar | -5.26% | 6 |
| Apr | +0.51% | 6 |
| May | -4.08% | 6 |
| Jun | +0.42% | 6 |
| Jul | +5.93% | 5 |
| Aug | -6.03% | 5 |
| Sep | -7.21% | 5 |
| Oct | -1.89% | 5 |
| Nov | +0.66% | 5 |
| Dec | -2.07% | 5 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $13.79
SMA 50: $13.81
SMA 200: $16.42
Current: $15.31
EMA 12: $14.17
EMA 26: $13.96
MACD: 0.2115 | Signal: 0.1750
BULLISH
ADX (14): 15.78
RANGE
+DI: 27.11
−DI: 10.91
Momentum Oscillators
RSI (14): 70.84
OVERBOUGHT
Stoch %K: 99.08
Stoch %D: 92.71
Williams %R: -0.89
Volume & Volatility
BB Upper: $14.81
BB Lower: $12.77
OVERBOUGHT
OBV: -32,027,466
Vol SMA 20: 1,259,991
Vol ROC: 5.92%
ATR: $0.51
True Range: $0.53
HV 20: 33.8%
HV 30: 33.5%
HV 60: 31.5%
Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:18.110000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
Outpatient surgery giant or home-based respiratory care leader, which business model stands out as healthcare spending patterns evolve and margins diverge?
Earnings History
6 of 8 under expected move
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-06 | After-Close | 10.96% | 3.48% | 0.32x | Within |
| 2024-11-12 | After-Close | 4.48% | 13.67% | 3.05x | Exceeded |
| 2025-03-03 | Pre-Market | 9.45% | 0.34% | 0.04x | Within |
| 2025-05-12 | Pre-Market | 15.47% | 4.91% | 0.32x | Within |
| 2025-08-05 | Pre-Market | 6.86% | 0.34% | 0.05x | Within |
| 2025-11-10 | Pre-Market | 9.65% | 25.12% | 2.60x | Exceeded |
| 2026-03-02 | After-Close | 13.23% | 10.74% | 0.81x | Within |
| 2026-05-05 | Pre-Market | 16.46% | 0.52% | 0.03x | Within |
Options Activity
- IV Rank (30D)
- 18.57
- IV Rank (7D)
- 100
- Avg IV
- 105.1%
- Straddle (30D)
- $1.88
- Straddle (7D)
- $0.88
- P/C Volume
- 0.17
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Volatility Surface
Enter a ticker to render the implied volatility surface.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 1.02
- Correlation (SPY)
- 26.8%
- R²
- 0.07
- Ann. Volatility
- 47.0%
- SPY Volatility
- 12.3%
Above average volatility - stock moves with market amplification
Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
? 13F Guide
Diluted shares outstanding: 127,440,500 (as of 2026-03-31)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
10 filers$22.90M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC Custodian | $11.47M | 50.09% | 2026-03-31 |
| 2 | LMR Partners LLP | $3.34M | 14.58% | 2026-03-31 |
| 3 | MILLENNIUM MANAGEMENT LLC Custodian | $2.68M | 11.71% | 2026-03-31 |
| 4 | WOLVERINE TRADING, LLC Custodian | $1.95M | 8.54% | 2025-09-30 |
| 5 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $1.35M | 5.90% | 2026-03-31 |
| 6 | IMC-Chicago, LLC Custodian | $1.20M | 5.25% | 2026-03-31 |
| 7 | Centiva Capital, LP | $596.00K | 2.60% | 2026-03-31 |
| 8 | Walleye Capital LLC | $158.54K | 0.69% | 2026-03-31 |
| 9 | SIMPLEX TRADING, LLC Custodian | $128.74K | 0.56% | 2026-03-31 |
| 10 | GROUP ONE TRADING LLC Custodian | $17.88K | 0.08% | 2026-03-31 |
9 filers$18.45M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC Custodian | $10.58M | 57.31% | 2026-03-31 |
| 2 | Centiva Capital, LP | $3.03M | 16.43% | 2026-03-31 |
| 3 | WOLVERINE TRADING, LLC Custodian | $2.64M | 14.28% | 2025-09-30 |
| 4 | IMC-Chicago, LLC Custodian | $799.83K | 4.33% | 2026-03-31 |
| 5 | Crawford Fund Management, LLC | $750.96K | 4.07% | 2026-03-31 |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $312.30K | 1.69% | 2026-03-31 |
| 7 | Walleye Capital LLC | $226.48K | 1.23% | 2026-03-31 |
| 8 | SIMPLEX TRADING, LLC Custodian | $91.78K | 0.50% | 2026-03-31 |
| 9 | GROUP ONE TRADING LLC Custodian | $28.61K | 0.15% | 2026-03-31 |
Insider Activity
Latest: 2026-06-09
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-09 | CLIFFORD G ADLERZ | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | Teresa DeLuca | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | John A Deane | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | Lloyd H Dean | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | BLAIR E HENDRIX | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | BRENT TURNER | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-06-09 | Laura L Forese | Director | Award (A) | +11,670 | $13.71 | $160.0K | EDGAR |
| 2026-03-16 | Jennifer Baldock | Chief Admin & Dev Officer | Sell (S) | −5,798 | $13.17 | -$76.4K | EDGAR |
| 2026-03-16 | Marissa Brittenham | Chief Strategy Officer | Sell (S) | −3,657 | $12.54 | -$45.9K | EDGAR |
| 2026-03-16 | Jason Eric Evans | Chief Executive Officer | Sell (S) | −20,400 | $12.47 | -$254.4K | EDGAR |
| 2026-03-16 | Danielle Burkhalter | Chief Human Resources Officer | Sell (S) | −3,469 | $12.83 | -$44.5K | EDGAR |
| 2026-03-16 | David T Doherty | Chief Financial Officer | Sell (S) | −8,867 | $12.50 | -$110.8K | EDGAR |
| 2026-03-09 | Justin Robert Oppenheimer | COO & National Group President | Award (A) | +42,523 | $14.11 | $600.0K | EDGAR |
| 2026-03-09 | William Trenton Webb | American Group President | Mixed | +29,826 | $14.10 | $421.3K | EDGAR |
| 2026-03-09 | Danielle Burkhalter | Chief Human Resources Officer | Mixed | +35,494 | $14.03 | $504.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
32 insiders · @ $15.31
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | SAMI MNAYMNEH | 10%+ Owner | 26,455,651 | $405.04M | -$100.66M | 1 | 2015-10-23 |
| 2 | Michael Thomas Doyle | Chief Executive Officer | 3,122,474 | $47.81M | -$2.91M | 6 | 2017-11-15 |
| 3 | Jason Eric Evans | Chief Executive Officer | 920,386 | $14.09M | -$6.16M | 34 | 2026-03-16 |
| 4 | Jennifer Baldock | Chief Admin & Dev Officer | 326,474 | $5.00M | -$4.75M | 39 | 2026-03-16 |
| 5 | David T Doherty | Chief Financial Officer | 221,679 | $3.39M | -$3.65M | 23 | 2026-03-16 |
| 6 | Teresa Sparks | Executive VP & CFO | 192,360 | $2.95M | $0 | 5 | 2018-01-03 |
| 7 | THOMAS F. COWHEY | Chief Financial Officer | 143,573 | $2.20M | -$1.16M | 13 | 2021-05-07 |
| 8 | Harrison R. Bane | National Group President | 120,794 | $1.85M | -$2.24M | 10 | 2025-09-08 |
| 9 | Justin Robert Oppenheimer | COO & National Group President | 120,259 | $1.84M | $0 | 2 | 2026-03-09 |
| 10 | Dennis Dean | Senior VP & Controller | 120,210 | $1.84M | $0 | 7 | 2018-04-05 |
| 11 | John Crysel | Group Pres., National Group | 113,329 | $1.74M | $0 | 5 | 2018-01-03 |
| 12 | Wayne S DeVeydt | Exec Chairman of the Board | 105,203 | $1.61M | -$9.79M | 19 | 2025-03-25 |
| 13 | ANTHONY TAPARO | Chief Growth Officer | 102,321 | $1.57M | -$4.82M | 22 | 2024-03-13 |
| 14 | Marissa Brittenham | Chief Strategy Officer | 94,196 | $1.44M | -$757.0K | 12 | 2026-03-16 |
| 15 | Bryan S Fisher | EVP, COO of SP Ntl Grp | 90,594 | $1.39M | $0 | 3 | 2018-09-05 |
| 16 | BRENT TURNER | Director | 86,594 | $1.33M | $245.0K | 12 | 2026-06-09 |
| 17 | Danielle Burkhalter | Chief Human Resources Officer | 76,864 | $1.18M | -$427.8K | 14 | 2026-03-16 |
| 18 | William Trenton Webb | American Group President | 74,249 | $1.14M | -$88.0K | 6 | 2026-03-09 |
| 19 | Bradley R. Owens | National Group President | 72,338 | $1.11M | -$1.30M | 19 | 2024-06-03 |
| 20 | CLIFFORD G ADLERZ | Director | 69,104 | $1.06M | $0 | 10 | 2026-06-09 |
| 21 | Teresa DeLuca | Director | 56,843 | $870.3K | -$658.9K | 23 | 2026-06-09 |
| 22 | John A Deane | Director | 45,922 | $703.1K | -$309.8K | 9 | 2026-06-09 |
| 23 | Laura L. Brocklehurst | Chief Human Resources Officer | 41,424 | $634.2K | -$342.5K | 15 | 2022-11-14 |
| 24 | BRANDAN LINGLE | Pres., Ancillary Svces. Grp. | 32,870 | $503.2K | -$181.5K | 4 | 2019-04-08 |
| 25 | George Goodwin | American Group President | 31,806 | $486.9K | -$7.12M | 23 | 2022-06-08 |
| 26 | R. DAVID KRETSCHMER | CSTO | 28,785 | $440.7K | $0 | 3 | 2019-04-03 |
| 27 | Patricia Anne Maryland | Director | 24,583 | $376.4K | -$455.2K | 6 | 2025-08-15 |
| 28 | Laura L Forese | Director | 18,531 | $283.7K | $0 | 2 | 2026-06-09 |
| 29 | Angela Justice | Chief Human Resources Officer | 17,602 | $269.5K | $0 | 3 | 2019-07-03 |
| 30 | Carollee Brinkman | President, National Group | 17,486 | $267.7K | $0 | 1 | 2019-03-19 |
| 31 | Lloyd H Dean | Director | 11,670 | $178.7K | $0 | 1 | 2026-06-09 |
| 32 | Adam T Feinstein | Director | 8,895 | $136.2K | -$78.3K | 4 | 2019-05-20 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/B Ratio | 1.2 |
| P/S Ratio | 0.6 |
| EV/EBITDA | 8.4 |
| TTM Revenue | $3.3B |
| TTM Net Income | $-0.1B |
| TTM EPS | $-0.59 |
| ROE | -4.5% |
| Dividend Yield | 11.35% |
| Debt/Equity | 2.20 |